REGULATION OF ANTIBIOTIC SYNTHESIS IN STREPTOMYCES
Project Number5R01AI024202-03
Contact PI/Project LeaderJONES, GEORGE H
Awardee OrganizationUNIVERSITY OF MICHIGAN AT ANN ARBOR
Description
Abstract Text
The studies proposed in this application are designed to examine
the mechanism and regulation of actinomcyin synthesis in
Streptomyces antibioticus. In previous experiments, the
structural gene for phenoxazinone synthase (PHS), a key enzyme
in the actinomycin biosynthetic pathway was cloned. In the
present application it is proposed to: (1) Characterize a recently
isolated DNA fragment which overlaps the ends of the PHS gene
for sequences reponsible for glucose catabolite repression of PHS
synthesis. Techniques of in vitro mutagenesis will be used to
identify those sequences: (2) Clone the gene for the enzyme
which activates 4-methyl-3-hydroxyanthranilic acid, the precursor
of the phenoxazinone chromphore in the actinomycin biosynthetic
pathway: (3) Characterize the clones obtained in (2) using
molecular biological and biochemical techniques; (4) Examine the
possible regulation of gene expression in S. antibioticus by RNA
polymerase. For these studies, experiments will be designed to
examine the possible specificity of RNA polymerase sigma factors
in the transcription of S. antibioticus genes.
The proposed studies are significant because they will provide
information relating to the regulation of antibiotic synthesis in
particular and secondary metabolism in general in an extremely
interesting class of organisms. The proposed research will also
provide information on gene organization and expression generally
in prokaryotes. Finally, the proposed studies may lead to a level
of understanding of the mechanisms of antibiotic production
which will allow the use of genetic engineering techniques to
construct organisms which are capable of hyperproduction of
existing antibiotics or the production of new antibiotics. Thus,
the proposed studies will have potential applications to industry
and to clinical and veterniary medicine.
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
073133571
UEI
GNJ7BBP73WE9
Project Start Date
01-December-1986
Project End Date
31-December-1989
Budget Start Date
01-December-1988
Budget End Date
31-December-1989
Project Funding Information for 1989
Total Funding
$97,631
Direct Costs
$61,403
Indirect Costs
$36,228
Year
Funding IC
FY Total Cost by IC
1989
National Institute of Allergy and Infectious Diseases
$97,631
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI024202-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI024202-03
Patents
No Patents information available for 5R01AI024202-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI024202-03
Clinical Studies
No Clinical Studies information available for 5R01AI024202-03
News and More
Related News Releases
No news release information available for 5R01AI024202-03
History
No Historical information available for 5R01AI024202-03
Similar Projects
No Similar Projects information available for 5R01AI024202-03